Skip to main content
Log in

Synthesis and Myorelaxant Activity of 1,3-Bis-(5-ammoniopentyl)-6-methyluracil Dibromides

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Some representatives of 1,3-bis-(5-ammoniopentyl)uracil dibromides with the anticholinesterase type of activity are classified as highly/moderately toxic in mice and as slightly toxic/practically nontoxic in daphnia. Under the conditions of functional testing (treadmill running test in mice, i.p.), compounds with less bulky substituents (H, F, Br, CH3, CN, NO2, and CH3O groups) at positions 5 and 6 of the uracil cycle are more effective and safer than proserine and BW284c51: (a) they induce the development of a clearly pronounced myorelaxant effect lasting over not less than one day (ED50 = 0.03 – 0.11 µM/kg), (b) the ratio LD50/ED50 is below 76.67. An increase in length of the aliphatic radical in position 5 of the uracil cycle leads to a gradual increase in the toxicity with respect to daphnia, while the toxicity with respect to mice exhibits a decrease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. V. V. Zobov, K. A. Petrov, A. A. Aslyamova, et al., Sovr. Probl. Toksikol. (Kiev), no. 3, 25–33 (2004).

  2. V. V. Zobov, A. A. Aslyamova, L. A. Berezinsky, et al., Khim.-Farm. Zh., 38(10), 20–23 (2004).

    Google Scholar 

  3. G. S. Fomin, Water: Chemical, Bacterial, and Radioactive Safety Monitored According to International Standards [in Russian], Protector, Moscow (1995), pp. 410–458.

    Google Scholar 

  4. B. J. Jones and D. J. Roberts, J. Pharm. Pharmacol., 20, 302–304 (1968).

    PubMed  CAS  Google Scholar 

  5. Yu. G. Bobkov, V. M. Vinogradov, V. V. Katkov, et al., Pharmacological Correction of Fatigue [in Russian], Meditsina, Moscow (1984).

    Google Scholar 

  6. V. B. Prozorovskii and N. V. Savateev, Nonanticholinesterase Mechanisms in the Action of Anticholinesterase Agents [in Russian], Meditsina, Leningrad (1976), pp. 62–80.

    Google Scholar 

  7. F. Hobbinger, in: Handbook of Experimental Pharmacology, E. Zamis (ed.), Springer-Verlag, Berlin (1976), Vol. 42, pp. 487–581.

    Google Scholar 

  8. I. V. Sanotskii and I. P. Ulanova, Criteria of Hazard in Hygiene and Toxicology of Dangerous Chemical Compounds [in Russian], Meditsina, Moscow (1975), pp. 55–59.

    Google Scholar 

  9. A Collection of Normative and Methodological Documentation on Handling Production and Consumption Wastes [in Russian], Logus, Moscow (1996), Supplement 1, pp. 67–68.

  10. V. V. Zobov, L. A. Berezinskii, V. S. Reznik, and V. D. Akamsin, Khim.-Farm. Zh., 36(11), 21–22 (2002).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

__________

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 39, No. 6, pp. 12 – 14, June, 2005.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zobov, V.V., Petrov, K.A., Aslyamova, A.A. et al. Synthesis and Myorelaxant Activity of 1,3-Bis-(5-ammoniopentyl)-6-methyluracil Dibromides. Pharm Chem J 39, 292–295 (2005). https://doi.org/10.1007/s11094-005-0136-6

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-005-0136-6

Keywords

Navigation